Quercetin — Stack & Timing
Educational timing and stacking information based on how Quercetin has been studied. Not a prescription. Not medical advice.
This is educational information only. Consult a healthcare provider before starting any supplement.
Stack & Timing Guidance
Educational summary based on how Quercetin has been studied and commonly used.
Commonly studied timing
Quercetin is fat-soluble and its bioavailability is significantly improved when taken with a meal containing dietary fat; post-workout timing has been explored in the context of attenuating exercise-induced muscle damage and delayed-onset muscle soreness.
Dose ranges used in studies
Daily doses in research contexts typically range from 250–1000 mg, with lower doses (250–500 mg) used for ongoing anti-inflammatory and antioxidant support and higher intermittent doses studied in senolytic protocols; bioavailability varies substantially by formulation, with encapsulated or phytosome forms showing improved absorption per meta-analysis evidence.
↑ These are ranges from research studies, not personal dosing recommendations. Discuss with a clinician.
Commonly paired with
Quercetin is proposed to act as a zinc ionophore, potentially facilitating intracellular zinc uptake; this combination is of particular interest for immune support
Vitamin C may help regenerate quercetin from its oxidized form and enhance its antioxidant activity; both have complementary anti-inflammatory mechanisms
Both are polyphenols with overlapping anti-inflammatory, antioxidant, and potential bone-metabolism benefits, and are commonly co-studied in nutraceutical research
Curcumin and quercetin share complementary anti-inflammatory pathways and are frequently combined in formulations targeting inflammation, joint health, and cardiovascular risk
Safety & interactions
Quercetin is generally considered safe at commonly studied doses (up to ~1000 mg/day) in short-to-medium term use; a dedicated safety review indicates a favorable profile at these levels, though very high doses or prolonged use have not been thoroughly characterized in humans. At high doses, mild gastrointestinal discomfort has been reported.
- •May interact with anticoagulant/antiplatelet drugs (e.g., warfarin) by affecting platelet aggregation and drug metabolism
- •May inhibit CYP3A4 and CYP2C8 enzymes, potentially altering the metabolism of certain medications including some statins and chemotherapy agents
- •May potentiate the effects of antihypertensive medications given modest blood-pressure-lowering effects identified in meta-analysis
- •May interact with antibiotics, particularly fluoroquinolones, by chelating metal ions or altering gut microbiota
Individuals on anticoagulant therapy, immunosuppressants, or drugs with narrow therapeutic windows should consult a physician before use due to potential CYP enzyme interactions. Pregnant or breastfeeding individuals should exercise caution given insufficient safety data in these populations. Those with kidney disease should use caution, as high-dose quercetin metabolites may place additional renal burden.